FOS and migraine disorder: Another compound, Ligustrazine (40mg, intravenously injected), showed anti-migraine potentials through inhibiting the c-fos/ERK signalling pathway in the trigeminal ganglion nerve of nitroglycerin-induced migraine rat models (Li et al., 2021).